Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM®, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, “universal” influenza candidate, OVX836, which is currently in Phase 2 clinical trials with over 1200 subjects tested and encouraging efficacy proof of concept data. Osivax’ ambition is to develop a pan-respiratory virus vaccine to prevent all strains of influenza and all variants of sarbecovirus in one single shot. The company will expand into other infectious disease indications through combinations and collaborations worldwide.

Bpifrance

European Innovation Council

Anaxago

Meusinvest (Noshaq)

Cédric Delorme

Osivax

Vir Biotechnology is a biotechnology company focused on the development of therapies for infectious diseases, including vaccines and immunotherapies.

Vir Biotechnology

Bharat Biotech is a leading biotechnology company specializing in the development of vaccines and immunotherapies for various infectious diseases and public health concerns.

Bharat Biotech

OncoHost is a company that focuses on the development of personalized immunotherapy solutions for cancer treatment, leveraging advanced technologies and data analytics.

OncoHost

Themis Bioscience is a biotechnology company specializing in the development of vaccines for infectious diseases, with a particular emphasis on emerging and neglected diseases.

Themis Bioscience

Cellestia is a biotechnology company dedicated to the development of targeted therapies for cancer, focusing on the discovery and development of innovative small molecule drugs.

Cellestia

Brenus Pharma is a biopharmaceutical company focused on the development of novel therapies for autoimmune conditions and inflammatory diseases.

Brenus Pharma

Seekyo is a biotechnology company specializing in the development of innovative therapies for infectious diseases and immune-related disorders.

Seekyo

Step Pharma is a biotechnology company dedicated to the development of novel treatments for genetic diseases and immune-related disorders.

Step Pharma

OSIVAX is a biotechnology company specializing in the development of vaccines and immunotherapies. The company leverages its proprietary technology platforms to design and produce vaccines aimed at preventing and treating infectious diseases, cancers, and autoimmune conditions.

OSIVAX

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 14, 2024 8:37 AM	99c392be
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	ffd3b8e6
crunchbase profile	general
li profile	general	May 14, 2024 8:37 AM	65c0403f
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:OSIVAX

OSIVAX